Future Studies
A staged approach:
- Critical parameters of method must be identified, evaluated and formally validated.
- Proposed surrogate needs to be demonstrated to be relevant to target site.
- DPK results must be correlated to clinical outcomes.
- DPK then to be tested in specific therapeutic classes, different target sites in skin, different delivery systems.